Journal of Applied Physiology Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 98: 722-731, 2005. First published October 22, 2004; doi:10.1152/japplphysiol.00715.2004
8750-7587/05 $8.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
98/2/722    most recent
00715.2004v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerasimovskaya, E. V.
Right arrow Articles by Stenmark, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerasimovskaya, E. V.
Right arrow Articles by Stenmark, K. R.

HIGHLIGHTED TOPICS
Pulmonary Circulation and Hypoxia

Activation of phosphatidylinositol 3-kinase, Akt, and mammalian target of rapamycin is necessary for hypoxia-induced pulmonary artery adventitial fibroblast proliferation

Evgenia V. Gerasimovskaya, Doug A. Tucker, and Kurt R. Stenmark

Developmental Lung Biology Laboratory, University of Colorado Health Sciences Center, Denver, Colorado

Submitted 9 July 2004 ; accepted in final form 18 October 2004

In contrast to cell types in which exposure to hypoxia causes a general reduction of metabolic activity, a remarkable feature of pulmonary artery adventitial fibroblasts is their ability to proliferate in response to hypoxia. Previous studies have suggested that ERK1/2, phosphatidylinositol 3-kinase (PI3K), Akt, and mammalian target of rapamycin (mTOR) are activated by hypoxia and play a role in a variety of cell responses. However, the pathways involved in mediating hypoxia-induced proliferation are largely unknown. Using pharmacological inhibitors, we established that PI3K-Akt, mTOR-p70 ribosomal protein S6 kinase (p70S6K), and EKR1/2 signaling pathways play a critical role in hypoxia-induced adventitial fibroblast proliferation. We found that exposure of serum-starved fibroblasts to 3% O2 resulted in a time-dependent activation of PI3K and transient phosphorylation of Akt. However, activation of PI3K was not required for activation of ERK1/2, implying a parallel involvement of these pathways in the proliferative response of fibroblasts to hypoxia. We found that hypoxia induced significant increases in mTOR, p70S6K, 4E-BP1, and S6 ribosomal protein phosphorylation, as well as dramatic increases in p70S6K activity. The activation of p70S6K/S6 pathway was sensitive to inhibition by rapamycin and LY294002, indicating that mTOR and PI3K/Akt are upstream signaling regulators. However, the magnitude of hypoxia-induced p70S6K activity and phosphorylation suggests involvement of additional signaling pathways. Thus our data demonstrate that hypoxia-induced adventitial fibroblast proliferation requires activation and interaction of PI3K, Akt, mTOR, p70S6K, and ERK1/2 and provide evidence for hypoxic regulation of protein translational pathways in cells exhibiting the capability to proliferate under hypoxic conditions.

pulmonary hypertension; protein synthesis; environmental stress; oxygen sensing; vascular remodeling



Address for reprint requests and other correspondence: K. R. Stenmark, Professor of Pediatrics, Univ. of Colorado Health Sciences Center, 4200 E. 9th Ave., Box B131, Denver, CO 80262 (E-mail: Kurt.Stenmark{at}UCHSC.edu)




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. M. Carlin, A. J. Peacock, and D. J. Welsh
Fluvastatin Inhibits Hypoxic Proliferation and p38 MAPK Activity in Pulmonary Artery Fibroblasts
Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 447 - 456.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. S. McMurtry, S. Bonnet, E. D. Michelakis, S. Bonnet, A. Haromy, and S. L. Archer
Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study
Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L933 - L940.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Li, M. Petrimpol, K. D. Molle, M. N. Hall, E. J. Battegay, and R. Humar
Hypoxia-Induced Endothelial Proliferation Requires Both mTORC1 and mTORC2
Circ. Res., January 5, 2007; 100(1): 79 - 87.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
K. R. Stenmark, N. Davie, M. Frid, E. Gerasimovskaya, and M. Das
Role of the Adventitia in Pulmonary Vascular Remodeling
Physiology, April 1, 2006; 21(2): 134 - 145.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
E Sivridis, A Giatromanolaki, and M I Koukourakis
Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress
J. Clin. Pathol., October 1, 2005; 58(10): 1033 - 1038.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. C. Sieck
Commentary
J Appl Physiol, February 1, 2005; 98(2): 714 - 714.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.